Form 4: CEO Sells EXPO Shares After Option Exercise
Insider Transaction Report
Exponent Inc.'s President & CEO, Catherine Corrigan, sold 3,225 shares of common stock after exercising stock options under a Rule 10b5-1 plan.
Summary
- Catherine Corrigan, President & CEO and a Director of Exponent Inc. (EXPO), reported transactions involving the company's common stock.
- On December 15, 2025, Corrigan exercised 3,225 non-qualified stock options at an exercise price of $25.405 per share.
- These options were part of a grant that becomes exercisable in four equal annual installments.
- Immediately following the option exercise on December 15, 2025, Corrigan sold 3,225 shares of common stock at a price of $70.7387 per share.
- The transactions were made pursuant to a Rule 10b5-1 pre-arranged trading plan.
- Following these transactions, Corrigan directly beneficially owns 84,134 shares of common stock and 16,128 non-qualified stock options.
Sentiment
Score: 5
Explanation: The filing reports a pre-planned insider sale of shares following option exercise, which is a routine event but represents a reduction in direct beneficial ownership by a key executive. It does not inherently indicate a change in company fundamentals.
Negatives
- The sale of shares by a key executive, even if pre-planned, can sometimes be perceived as a lack of confidence by some investors, although it is often for personal liquidity or diversification.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Disclosure | The transactions were executed under a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities, indicating a pre-arranged trading strategy. | 12/15/2025 | This demonstrates adherence to insider trading regulations by pre-scheduling trades, reducing the perception of opportunistic trading. |
Stakeholder Impact
- Shareholders may note the reduction in direct beneficial ownership by the President & CEO, though the pre-planned nature of the sale under Rule 10b5-1 mitigates concerns about opportunistic selling.
Key Dates
| Date | Description |
|---|---|
| 12/15/2025 | Date of stock option exercise and subsequent sale of common stock. |
| 07/29/2026 | Expiration date of the non-qualified stock options. |
Recommendation
holdThe filing details a routine, pre-planned exercise of stock options and subsequent sale of shares by a key executive. Such transactions are common for personal financial planning, diversification, or tax purposes and do not typically signal a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this filing.
Keywords
Exponent Inc, EXPO, insider trading, Form 4, stock options, CEO, share sale, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.